Elon's Vision
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

Introducing D-Tetrasuper EC by Parkers Pharma: A Powerful 10% d-Tetramethrin Solution for Fast Elimination of Public Health Pests

by
May 21, 2025
in Stock
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Parkers Pharma, a leading pharmaceutical company, has announced the launch of their latest product, D-Tetrasuper EC. This advanced insecticidal solution, formulated with 10% d-Tetramethrin, offers swift and effective control of public health pests such as mosquitoes, flies, cockroaches, and other disease vectors. Developed under the guidance of Dr. Wathek Zair, D-Tetrasuper EC is designed for…

Source

Previous Post

Working from home is here to stay — if employees have their say, new research finds

Next Post

What the Biden Health Coverup Reveals About the Political Class

Next Post

What the Biden Health Coverup Reveals About the Political Class

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023
Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

January 31, 2025

An update on the National Nature Assessment

April 23, 2025
Employment Rights Bill clears final parliamentary hurdle and set to become law

Employment Rights Bill clears final parliamentary hurdle and set to become law

0

0

0

0
Employment Rights Bill clears final parliamentary hurdle and set to become law

Employment Rights Bill clears final parliamentary hurdle and set to become law

December 16, 2025
Stablecoins, Money Market Funds, and the Regulatory Mess We Refuse to Clean Up

Stablecoins, Money Market Funds, and the Regulatory Mess We Refuse to Clean Up

December 16, 2025
Global Human Freedom Still Depressed Years After the Pandemic: New Index

Global Human Freedom Still Depressed Years After the Pandemic: New Index

December 16, 2025

It’s Time to Renew Your Mises Membership

December 16, 2025

Recent News

Employment Rights Bill clears final parliamentary hurdle and set to become law

Employment Rights Bill clears final parliamentary hurdle and set to become law

December 16, 2025
Stablecoins, Money Market Funds, and the Regulatory Mess We Refuse to Clean Up

Stablecoins, Money Market Funds, and the Regulatory Mess We Refuse to Clean Up

December 16, 2025
Global Human Freedom Still Depressed Years After the Pandemic: New Index

Global Human Freedom Still Depressed Years After the Pandemic: New Index

December 16, 2025

It’s Time to Renew Your Mises Membership

December 16, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.